Sleep dysfunction in heart failure

Current Treatment Options in Neurology

Volumn 10, Issue 5, 2008, Pages 323-335

  Javaheri, Shahrokh ^a  

^a Sleepcare Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETAZOLAMIDE; ASCORBIC ACID; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CORTICOSTEROID; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; IRON; LOOP DIURETIC AGENT; OXYGEN; PLACEBO; PRAMIPEXOLE; RAMELTEON; ROPINIROLE; SILDENAFIL; THEOPHYLLINE; TRIAMTERENE; VERAPAMIL;

ALCOHOLIC BEVERAGE; AROUSAL; ARTIFICIAL HEART PACEMAKER; BEDTIME DOSAGE; CARDIAC GRAFT REJECTION; CENTRAL SLEEP APNEA SYNDROME; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG DOSE TITRATION; DRUG EXPOSURE; DRUG MECHANISM; DRUG METABOLISM; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; INSOMNIA; LOW DRUG DOSE; MORBIDITY; MORTALITY; OBESITY; ORTHODONTIC DEVICE; OXYGEN THERAPY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; RESTLESS LEGS SYNDROME; REVIEW; RISK FACTOR; SIDE EFFECT; SINUS BRADYCARDIA; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP STAGE; SURVIVAL RATE; SYSTOLIC HEART FAILURE; THERAPY EFFECT; TREATMENT RESPONSE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 58649093704     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-008-0035-8     Document Type: Review

References (90)

1. Javaheri S: Heart failure. In Principles and Practice of Sleep Medicine, edn 4. Edited by Kryger MH, Roth T, Dement WC. Philadelphia: WB Saunders; 2005: 1208-1217.
2. Javaheri S: Sleep-related breathing disorders in heart failure. In Heart Failure, A Companion to Braunwald's Heart Disease. Edited by Mann DL. Philadelphia: WB Saunders; 2004: 471-487.
3. Javaheri S, Parker TJ, Wexler L, et al.: Occult sleepdisordered breathing in stable congestive heart failure. Ann Intern Med 1995, 122:487-492. [Published erratum appears in Ann Intern Med 1995, 123: 77.]
4. Javaheri S, Parker TJ, Liming JD, et al.: Sleep apnea in 81 ambulatory male patients with stable heart failure: Types and their prevalences, consequences, and presentations. Circulation 1998, 97:2154-2159.
5. Javaheri S: Sleep disorders in systolAc heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006, 106:21-28.
6. Somers VK, Dyken ME, Mark AL, et al.: Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993, 328:303-307.
7. Javaheri S: Sleep and cardiovascular disease. Sleep Med Clin 2007, 2:529-642.
8. Hanly PJ, Millar TW, Steljes DG, et al.: Respiration and abnormal sleep in patients with congestive heart failure. Chest 1989, 96:480-488.
9. Sin DD, Fitzgerald F, Parker JD, et al.: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160:1101-1106.
10. Solin P, Bergin P, Richardson M, et al.: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999, 99:1574-1579.
11. Tremel F, Pépin JL, Veale D, et al.: High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999, 20:1201-1209.
12. Ferrier K, Campbell A, Yee B, et al.: Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005, 128:2116-2122.
13. Zhao Z, Sullivan C, Liu Z, et al.: Prevalence and clinical characteristics of sleep apnea in Chinese patients with heart failure. Int J Cardiol 2007, 118:122-123.
14. Wang H, Parker J, Newton G, et al.: Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007, 49:1625-1631.
15. Lofaso F, Verschueren P, Rande JL, et al.: Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 1994, 106:1689-1694.
16. Schulz R, Blau A, Borgel J, et al.: Sleep apnea in heart failure. Eur Respir J 2007, 29:1201-1205.
17. Oldenburg O, Lamp B, Faber L, et al.: Sleep-disordered breathing in patients with symptomatic heart failure: A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007, 9:251-257.
18. Lanfranchi P, Somers VK, Braghiroli A, et al.: Central sleep apnea in left ventricular dysfunction prevalence and implications for arrhythmic risk. Circulation 2003, 107:727-732.
19. Vazir A, Hastings P, Dayer M, et al.: A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007, 9:243-250.
20. Christ M, Sharkova Y, Fenske H, et al.: Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients. Int J Cardiol 2007, 116:62-69.
21. Skobel E, Norra C, Sinha A, et al.: Impact of sleep-related breathing disorders on health-related quality of life in patients with chronic heart failure. Eur J Heart Fail 2005, 7:505-511.
22. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
23. Chan J, Sanderson J, Chan W, et al.: Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997, 111:1488-1493.
24. Arias M, Garcia-Rio F, Alonso-Fernandez A, et al.: Obstructive sleep apnea syndrome affects left ventricular diastolic function. Effects of nasal continuous positive airway pressure in men. Circulation 2005, 112:375-383.
25. Shivalkar B, Van De Heyning C, Kerremans M, et al.: Obstructive sleep apnea syndrome. More insight on structural and functional cardiac alterations and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006, 47:1433-1439.
26. Amin RS, Kimball TR, Kalra M, et al.: Left ventricular function in children with sleep disordered breathing. Am J Cardiol 2005, 95:801-804.
27. Kasai T, Narui K, Dohi T, et al.: Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008, 133:690-696.
28. Javaheri S, Shukla R, Zeigler H, et al.: Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. Am J Cardiol 2007, 49:2028-2034.
29. Arzt M, Floras JS, Logan AG, et al.: Suppression of central sleep apnea by continuous positive air pressure and transplant-free survival in heart failure. Circulation 2007, 115:3173-3180.
30. Hanly P, Zuberi-Khokhar N: Periodic limb movements during sleep in patients with congestive heart failure. Chest 1996, 109:1497-1502.
31. Teschler H, Döhring J, Wang YM, Berthon-Jones M: Adaptive pressure support servo-ventilation: A novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 164:614-619.
32. Pennestri MH, Montplaisir J, Colombo R, et al.: Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007, 68:1213-1218.
33. Nanas J, Matsouka C, Karageorgopoulos D, et al.: Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006, 48:2485-2489.
34. Okonko DO, Anker SD: AnemiaPin chronic heart failure: pathogenetic mechanisms. J Card Fail 2004, 10:S5-S9.
35. Guggisberg AG, Hess CW, Mathis J: The significance of the sympathetic nervous system in the pathophysiology of periodic leg movements in sleep. Sleep 2007, 30:755-766.
36. Javaheri S, Abraham W, Brown C, et al.: Prevalence of obstructive sleep apnea and periodic limb movements in 45 subjects with heart transplantation. Eur Heart J 2004, 25:260-266.
37. Arendt J, Bojkowski C, Franey C, et al.: Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: Abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985, 60:1166-1173.
38. Scherrer U, Vissing S, Morgan B, et al.: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990, 323:693-699.
39. NIH State of the Science Conference statement on manifestations and management of chronic insomnia in adults. J Clin Sleep Med 2005, 1:412-421.
40. Lesman-Leegte I, Jaarsma T, Sanderman R, et al.: Depressive symptoms are prominent among elderly hospitalised heart failure patients. Eur J Heart Fail 2006, 8:634-640.
41. Bonnet M, Arand D: 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995, 18:581-588.
42. Burgos I, Richter L, Klein T, et al.: Increased nocturnal interleukin-6 excretion in patients with primary insomnia: A pilot study. Brain Behav Immun 2006, 20:246-253.
43. Vgontzas A, Tsigos C, Bixler E, et al.: Chronic insomnia and activity of the stress system: A preliminary study. J Psychosom Res 1998, 45:21-31.
44. Calle EE, Thun MJ, Petrelli JM, et al.: Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999, 341:1097-1105.
45. Kenchaiah S, Evans JC, Levy D, et al.: Obesity and the risk of heart failure. N Engl J Med 2002, 347:305-313.
46. Roizenblatt S, Guilleminault C, Poyares D, et al.: A double-blind, placebo-controlled, crossover study of sildenafil in obstructive sleep apnea. Arch Intern Med 2006, 166:1763-1767.
47. Javaheri S: Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000, 101:392-397.
48. Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 248:1233-1241.
49. Mansfield DR, Gollogly C, Kaye DM: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361-366.
50. Egea CJ, Aizpuru F, Pinto JA, et al.: Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: A multicenter study. Sleep Med 2007 Sep 26 (Epub ahead of print).
51. Smith LA, Vennelle M, Gardner RS, et al.: Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnea: A randomized placebo-controlled trial. Eur Heart J 2007, 28:1221-1227.
52. Faccenda J, Mackay T, Boon N, et al.: Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001, 163:344-348.
53. Becker H, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68-73.
54. Eskafi M: Sleep apnoea in patients with stable congestive heart failure an intervention study with a mandibular advancement device. Swed Dent J Suppl 2004, 168:1-56.
55. Javaheri S: Pembrey's dream: The time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. Chest 2003, 123:322-325.
56. Hudgel D, Chapman KR, Franks C, et al.: Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxemia during sleep. Am Rev Respir Dis 1987, 135:899-906.
57. Stoschitzky K, Sakotnik A, Lercher P, et al.: Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999, 55:111-115.
58. Javaheri S: Heart failureEand sleep apnea: emphasis on practical therapeutic options. Clin Chest Med 2003, 24:207-222.
59. Guilleminault C, Clerk A, Labanowski M, et al.: Cardiac failure and benzodiazepines. Sleep 1993, 16:524-528.
60. Davies RJO, Harrington KJ, Ormerod JM, et al.: Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. Am Rev Respir Dis 1993, 147:630-634.
61. Buckle P, Millar T, Kryger M: The effects of short-term nasal CPAP on Cheyne-Stokes respiration in congestive heart failure. Chest 1992, 102:31-35.
62. Keily JL, Deegan P, Buckley A, et al.: Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: Importance of underlying cardiac rhythm. Thorax 1998, 53:956-962.
63. Sin DD, Logan AG, Fitzgerald FS, et al.: Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000, 102:61-66.
64. Naughton MT, Bernard DC, Liu PP, et al.: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995, 152:473-479.
65. Bradley T, Logan A, Kimoff J, et al.: Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2006, 353:2025-2033.
66. Javaheri S: CPAP should not be used for central sleep apnea in congestive heart failure patients. J Clin Sleep Med 2006, 2:399-402.
67. Pepperell J, Maskell N, Jones D, et al.: A randomized controlled trial of adaptive ventilation for Cheyne-stokes breathing in heart failure. Am J Respir Crit Care Med 2003, 168:1109-1114.
68. Szollosi I, O'Driscoll DM, Dayer MJ, et al.: Adaptive servoventilation and deadspace: Effects on central sleep apnoea. J Sleep Res 2006, 15:199-205.
69. Philippe C, Stoica-Herman M, Drouot X, et al.: Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006, 92:337-342.
70. Kasai T, Narui K, Dohi T, et al.: First experience of using new adaptive servo-ventilation device for Cheyne-Stokes respiration with central sleep apnea among Japanese patients with congestive heart failure: report of 4 clinical cases. Circ J 2006, 70:1148-1154.
71. Garrigue S, Bordier P, Jaïs P, et al.: Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002, 346:404-412.
72. Sinha A, Skobel E, Breithardt O, et al.: Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 2004, 44:68-71.
73. Gabor J, Newman D, Barnard-Roberts V, et al.: Improvement in Cheyne-Stokes respiration following cardiac resynchronization therapy. Eur Respir J 2006, 26:95-100.
74. Abraham WT, Hayes DL: Cardiac resynchronization therapy for heart failure. Circulation 2004, 108:2596-2603.
75. Hanly PF, Millar TW, Steljes DG, et al.: The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989, 111:777-782.
76. Javaheri S, Ahmed M, Parker TJ, Brown CR: Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999, 22:1101-1106.
77. Staniforth AD, Kinneart WJM, Hetmanski DJ, et al.: Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998, 19:922-928.
78. Andreas S, Bingeli C, Mohacsi P, et al.: Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 2003, 123:366-371.
79. Andreas S, Clemens C, Sandholzer H, et al.: Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996, 27:1486-1490.
80. Sasayama S, Izumi T, Seino Y, et al.: Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J 2006, 70:1-7.
81. Shigemitsu M, Nishio K, Kusuyama T, et al.: Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea. Int J Cardiol 2007, 115:354-360.
82. Dowdell WT, Javaheri S, McGinnis W: Cheyne-Stokes respiration presenting as sleep apnea syndrome. Clinical and polysomnographic features. Am Rev Respir Dis 1990, 141:871-879.
83. Hu K, Li Q, Yang J, et al.: The effect of theophylline on sleep-disordered breathing in patients with stable chronic congestive heart failure. Chin Med J 2003, 116:1711-1716.
84. Javaheri S, Parker TJ, Wexler L, et al.: Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996, 335:562-567.
85. Javaheri S, Teppama LJ, Evers JAM: Effects of aminophylline on hypoxemia-induced ventilatory depression in cats. J Appl Physiol 1988, 64:1837-1843.
86. Javaheri S, Evers JAM, Teppema LJ: Increase in ventilation caused by aminophylline in the absence of changes in ventral extracellular fluid pH and PCO2. Thorax 1989, 44:121-125.
87. Javaheri S, Guerra LF: Lung function, hypoxic and hypercapnic ventilatory responses, and respiratory muscle strength in normal subjects taking oral theophylline. Thorax 1990, 45:743-747.
88. DeBacker W, Verbraecken J, Willemen M, et al.: Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995, 151:87-91.
89. Verbraecken J, Willemen M, DeCock W, et al.: Central sleep apnea after interrupting longterm acetazolamide therapy. Respir Physiol 1998, 112:59-70.
90. Javaheri S: Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006, 173:234-237.